Abstract

Recombinant production of pharmaceutical proteins like antigen binding fragments (Fabs) in the commonly-used production host Escherichia coli presents several challenges. The predominantly-used plasmid-based expression systems exhibit the drawback of either excessive plasmid amplification or plasmid loss over prolonged cultivations. To improve production, efforts are made to establish plasmid-free expression, ensuring more stable process conditions. Another strategy to stabilize production processes is lactose induction, leading to increased soluble product formation and cell fitness, as shown in several studies performed with plasmid-based expression systems. Within this study we wanted to investigate lactose induction for a strain with a genome-integrated gene of interest for the first time. We found unusually high specific lactose uptake rates, which we could attribute to the low levels of lac-repressor protein that is usually encoded not only on the genome but additionally on pET plasmids. We further show that these unusually high lactose uptake rates are toxic to the cells, leading to increased cell leakiness and lysis. Finally, we demonstrate that in contrast to plasmid-based T7 expression systems, IPTG induction is beneficial for genome-integrated T7 expression systems concerning cell fitness and productivity.

Highlights

  • E. coli is one of the most widely used hosts for recombinant protein production to date

  • Compatible strains like E. coli BL21 (DE3), have the λDE3 region integrated into the genome, where transcription of T7 RNA polymerase is controlled by the lacUV5 promoter

  • The actual specific lactose uptake rate was determined after an adaption phase ranging from 2 h to 5 h, which depended on the specific glucose uptake rate

Read more

Summary

Introduction

E. coli is one of the most widely used hosts for recombinant protein production to date. Plasmids are used for recombinant protein production in E. coli, including the most frequently employed pET vectors, commercially established by NovagenTM. Compatible strains like E. coli BL21 (DE3), have the λDE3 region integrated into the genome, where transcription of T7 RNA polymerase is controlled by the lacUV5 promoter. Transcription and translation of the GOI depends upon transcription and translation of the T7 RNA polymerase from the lacUV5 promoter. Transcription of the T7 RNA polymerase and the GOI are inhibited by the lac-repressor (LacI) which binds in a tetrameric structure to the respective operator sites [6]. Lac operator sites are located in (I) the native E. coli lac promoter (II) the lacUV5 promoter, which regulates transcription of the T7 RNA polymerase and (III) in the lac operator

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call